Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (mROS) generation pathways refer to the biochemical processes by which superoxide, hydrogen peroxide, and hydroxyl radicals are produced as byproducts of aerobic respiration. The primary sites of mROS production are Complex I (NADH dehydrogenase) and Complex III (ubiquinone-cytochrome c oxidoreductase) of the electron transport chain, where electrons can prematurely react with molecular oxygen (Murphy, M. P., 2009, Biochemical Journal). While physiological levels of mROS act as vital signaling molecules for cellular adaptation, excessive production leads to oxidative damage of mitochondrial DNA, lipids, and proteins, contributing to mitochondrial dysfunction (Sies, H., & Jones, D. P., 2020, Nature Reviews Molecular Cell Biology). This dysfunction is a central driver in the pathogenesis of neurodegenerative conditions like Parkinson's disease and cardiovascular disorders (Zorov, D. B., et al., 2014, Physiological Reviews). Therapeutic interventions often focus on mitochondria-targeted antioxidants, such as MitoQ, or peptides like Elamipretide that stabilize the inner mitochondrial membrane to mitigate pathological ROS leakage (Brand, M. D., 2016, Biochemical Society Transactions).
Inhibition of electron transport chain complexes to reduce electron leakage, scavenging of superoxide and hydrogen peroxide within the mitochondrial matrix, and stabilization of mitochondrial membrane phospholipids to maintain structural integrity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species generation pathways (mROS pathways).